Journal
ISCIENCE
Volume 23, Issue 11, Pages -Publisher
CELL PRESS
DOI: 10.1016/j.isci.2020.101769
Keywords
-
Categories
Funding
- National Institutes of Health [R01 GM131399-01, K01 AG056673]
- Department of Defense [W81XWH1910309]
- Alzheimer's Association [AARF-17505009]
- Neuroscience Research Institute Pilot Award from The Ohio State University
- Chronic Brain Injury Pilot Award from The Ohio State University
- U.S. Department of Defense (DOD) [W81XWH1910309] Funding Source: U.S. Department of Defense (DOD)
Ask authors/readers for more resources
Alzheimer's disease (AD) is a progressive neurodegenerative disorder of the brain and the most common form of dementia among the elderly. The single-cell RNA-sequencing (scRNA-Seq) and single-nucleus RNA-sequencing (snRNA-Seq) techniques are extremely useful for dissecting the function/dysfunction of highly heterogeneous cells in the brain at the single-cell level, and the corresponding data analyses can significantly improve our understanding of why particular cells are vulnerable in AD. We developed an integrated database named scREAD (single-cell RNA-Seq database for Alzheimer's disease), which is as far as we know the first database dedicated to the management of all the existing scRNA-Seq and snRNA-Seq data sets from the human postmortem brain tissue with AD and mouse models with AD pathology. scREAD provides comprehensive analysis results for 73 data sets from 10 brain regions, including control atlas construction, cell-type prediction, identification of differentially expressed genes, and identification of cell-type-specific regulons.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available